We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 978 results
  1. Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South Sudan

    Background

    Seasonal malaria chemoprevention (SMC) using sulfadoxine-pyrimethamine plus amodiaquine (SP-AQ), is a community-based malaria preventive...

    Irene Molina-de la Fuente, María José Sagrado Benito, ... Carolina Nanclares in Malaria Journal
    Article Open access 10 November 2023
  2. Molecular surveillance for anti-malarial drug resistance and genetic diversity of Plasmodium falciparum after chloroquine and sulfadoxine-pyrimethamine withdrawal in Quibdo, Colombia, 2018

    Background

    Resistance to anti-malarial drugs is associated with polymorphisms in target genes and surveillance for these molecular markers is...

    Angela Patricia Guerra, Mario Javier Olivera, ... Naomi W. Lucchi in Malaria Journal
    Article Open access 28 October 2022
  3. Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial

    Background

    Exposure during pregnancy to malaria and sexually-transmitted infections is associated with adverse birth outcomes including low birth...

    Moussa Lingani, Serge H. Zango, ... Annie Robert in Malaria Journal
    Article Open access 17 March 2023
  4. A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates in Nigeria

    Background

    Malaria is a major public health issue with substantial risks among vulnerable populations. Currently, the World Health Organization (WHO)...

    Adebanjo J. Adegbola, Omotade A. Ijarotimi, ... Cally Roper in Malaria Journal
    Article Open access 01 March 2023
  5. Sub-microscopic Plasmodium falciparum parasitaemia, dihydropteroate synthase (dhps) resistance mutations to sulfadoxine–pyrimethamine, transmission intensity and risk of malaria infection in pregnancy in Mount Cameroon Region

    Background

    Plasmodium falciparum resistance to intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) continues to spread...

    Harry F. Mbacham, Diange M Mosume, ... Judith K. Anchang-Kimbi in Malaria Journal
    Article Open access 02 March 2023
  6. Effect of three years’ seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali

    Background

    In 2012, seasonal malaria chemoprevention (SMC) was recommended as policy for malaria control by the World Health Organization (WHO) in...

    Almahamoudou Mahamar, Kelsey M. Sumner, ... Alassane Dicko in Malaria Journal
    Article Open access 08 February 2022
  7. Intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine and parasite resistance: cross-sectional surveys from antenatal care visit and delivery in rural Ghana

    Background

    Despite decades of prevention efforts, the burden of malaria in pregnancy (MiP) remains a great public health concern....

    Atikatou Mama, Charity Ahiabor, ... Nicaise Tuikue Ndam in Malaria Journal
    Article Open access 26 March 2022
  8. Uptake of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP) in Uganda: a national survey

    Background

    In spite of the missed opportunities of sulfadoxine-pyrimethamine (IPTp-SP) in Uganda, scanty literature exist on malaria in pregnancy. To...

    Edward Kwabena Ameyaw in Malaria Journal
    Article Open access 07 October 2022
  9. Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India

    Background

    Artesunate plus sulfadoxine–pyrimethamine (ASP) is first-line treatment for uncomplicated Plasmodium falciparum malaria in most of India,...

    Ashish Pathak, Andreas Mårtensson, ... Johan Ursing in Malaria Journal
    Article Open access 14 August 2020
  10. Malaria Drug Discovery: How to Tackle the Problem of Drug Resistance

    Malaria has been a huge issue in previous years since it is an endemic disease that kills millions of people worldwide, regardless of their age....
    Chesta Shandilya, Shivani Singh, ... Indrakant K. Singh in Natural Product Based Drug Discovery Against Human Parasites
    Chapter 2023
  11. Risk factors for placental malaria, sulfadoxine-pyrimethamine doses, and birth outcomes in a rural to urban prospective cohort study on the Bandiagara Escarpment and Bamako, Mali

    Background

    Malaria in Mali remains a primary cause of morbidity and mortality, with women at high risk during pregnancy for placental malaria (PM)....

    Claudius Vincenz, Zachary Dolo, ... Beverly I. Strassmann in Malaria Journal
    Article Open access 31 March 2022
  12. Sulfadoxine-pyrimethamine parasitological efficacy against Plasmodium falciparum among pregnant women and molecular markers of resistance in Zambia: an observational cohort study

    Background

    The World Health Organization recommends the provision of intermittent preventive treatment during pregnancy (IPTp) with...

    Enesia Banda Chaponda, Sungano Mharakurwa, ... R. Matthew Chico in Malaria Journal
    Article Open access 22 January 2021
  13. Assessment of Plasmodium falciparum drug resistance associated molecular markers in Mandla, Madhya Pradesh, India

    Background

    Resistance against artemisinin-based combination therapy is one of the challenges to malaria control and elimination globally. Mutations in...

    Akansha Singh, Mrigendra P. Singh, ... Praveen K. Bharti in Malaria Journal
    Article Open access 11 December 2023
  14. Temporal evolution of sulfadoxine-pyrimethamine resistance genotypes and genetic diversity in response to a decade of increased interventions against Plasmodium falciparum in northern Ghana

    Background

    Anti-malarial drug resistance remains a key concern for the global fight against malaria. In Ghana sulfadoxine-pyrimethamine (SP) is used...

    Lucas N. Amenga-Etego, Victor Asoala, ... Dominic Kwiatkowski in Malaria Journal
    Article Open access 17 March 2021
  15. Antimalarial Drugs and Drug Resistance

    WHO estimated 241 million malaria cases in 2020 in 85 different malaria-endemic countries, more than in 2019. The reduction of cases due to...
    Chapter 2024
  16. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India

    Background

    Despite significant progress in eliminating malaria from the state of Odisha, India, the disease is still considered endemic. Artesunate...

    Ramakanta Rana, Nikhat Khan, ... Manoranjan Ranjit in Malaria Journal
    Article Open access 24 December 2022
  17. Artemisinin Resistance in Plasmodium falciparum Malaria

    The worldwide use of artemisinin-based combination therapies (ACTs) has contributed in recent years to a substantial reduction in deaths resulting...
    **aoxing Wang, Bo **ao, Lubin Jiang in Malaria Control and Elimination in China
    Chapter 2023
  18. Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso

    Background

    Artemisinin-based combinations therapy (ACT) is the current frontline curative therapy for uncomplicated malaria in Burkina Faso....

    Casimire Wendlamita Tarama, Harouna Soré, ... Adama Gansané in Malaria Journal
    Article Open access 20 July 2023
  19. Assessment of genetic polymorphisms associated with malaria antifolate resistance among the population of Libreville, Gabon

    Background

    Gabon is a malaria-threatened country with a stable and hyperendemic transmission of Plasmodium falciparum monoinfection. Malaria drug...

    Sylvatrie-Danne Dinzouna-Boutamba, Berthe Amélie Iroungou, ... Youn-Kyoung Goo in Malaria Journal
    Article Open access 14 June 2023
  20. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy

    Background

    Despite significant progress in eliminating malaria from the Kingdom of Saudi Arabia, the disease is still endemic in the southwestern...

    Aymen M. Madkhali, Hesham M. Al-Mekhlafi, ... Zaki M. Eisa in Malaria Journal
    Article Open access 02 December 2020
Did you find what you were looking for? Share feedback.